DNA.WS
Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share
DNA.WS
DNA.WS
Delisted
DNA.WS was delisted on the 3rd of September, 2024.
49 hedge funds and large institutions have $177M invested in Ginkgo Bioworks Holdings, Inc. Warrants, each whole warrant exercisable to purchase one-fortieth (1/40th) of a share of Class A Common Stock at an exercise price of $460.00 per share in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
83% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 12
Holders
49
Holding in Top 10
2
Calls
$362K
Puts
–
Top Buyers
| 1 | +$171M | |
| 2 | +$57.1K | |
| 3 | +$18K | |
| 4 |
TSS
Two Sigma Securities
New York
|
+$15K |
| 5 |
FLC
Fifth Lane Capital
Austin,
Texas
|
+$11K |
Top Sellers
| 1 | -$142K | |
| 2 | -$75.1K | |
| 3 | -$64.2K | |
| 4 |
TCA
Taconic Capital Advisors
New York
|
-$55K |
| 5 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
-$45.9K |